person · Reporting owner
Schornstein Alexander
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC.ASMB · Entity 5216 | 10% owner | November 22, 2024 | November 26, 2024 |
| Lite Strategy, Inc.LITS · Entity 7396 | 10% owner | December 18, 2025 | December 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASSEMBLY BIOSCIENCES, INC.
Report date November 22, 2024 · Filed November 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 728,113 |
Ending reported balance
After 2024-11-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-11-22 · Purchase · Acquired 17,024 · Balance 720,137 F1: The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds. F2: The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Row 2 · 2024-11-25 · Purchase · Acquired 2,976 · Balance 723,113 F3: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds. F4: 2,976 shares were purchased on November 25, 2024 at $15.00. Row 3 · 2024-11-25 · Purchase · Acquired 5,000 · Balance 728,113 F5: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds. F6: The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds.
F2: The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
F3: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.
F4: 2,976 shares were purchased on November 25, 2024 at $15.00.
F5: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds.
F6: The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Lite Strategy, Inc.
Report date December 18, 2025 · Filed December 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,674,862 |
Reported balance
After 2025-12-18 transaction · row 1
1 source rowRow 1 · 2025-12-18 · Sale · Disposed 690,611 · Balance 3,674,862 F1: The sales reported on this Form 4 represent shares sold by the reporting person on December 18, 2025, in the open market. F2: The price reported is the approximate weighted average at which the shares were sold. 690,611 shares were sold on December 18, 2025, in multiple transactions at prices ranging from approximately $1.35 to $1.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Upon completion of the sale, the Reporting Person is no longer a 10% owner of the Issuer's shares. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent shares sold by the reporting person on December 18, 2025, in the open market.
F2: The price reported is the approximate weighted average at which the shares were sold. 690,611 shares were sold on December 18, 2025, in multiple transactions at prices ranging from approximately $1.35 to $1.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Upon completion of the sale, the Reporting Person is no longer a 10% owner of the Issuer's shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2025 Filed Dec 22, 2025 21:15 UTC | Lite Strategy, Inc. LITS · Entity 7396 | SaleCommon Stock | 690,611 | $1.37 | $946,137.07 |
DisclosureSEC source: 0001079973-25-001891 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,674,862 F1 · kind: The sales reported on this Form 4 represent shares sold by the reporting person on December 18, 2025, in the open market. F2 · price: The price reported is the approximate weighted average at which the shares were sold. 690,611 shares were sold on December 18, 2025, in multiple transactions at prices ranging from approximately $1.35 to $1.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Upon completion of the sale, the Reporting Person is no longer a 10% owner of the Issuer's shares. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 14:15 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 5,000 | $14.85 | $74,250.00 |
DisclosureSEC source: 0001079973-24-001637 · ownership.xml · nonDerivative · entry 3 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728,113 F5 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds. F6 · price: The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 14:15 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 2,976 | $15.00 | $44,640.00 |
DisclosureSEC source: 0001079973-24-001637 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 723,113 F3 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds. F4 · price: 2,976 shares were purchased on November 25, 2024 at $15.00. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 14:15 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 17,024 | $14.87 | $253,104.32 |
DisclosureSEC source: 0001079973-24-001637 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720,137 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds. F2 · price: The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 13:15 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 10,000 | $14.58 | $145,800.00 |
DisclosureSEC source: 0001079973-24-001375 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703,113 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person on October 8, 2024, from the open market using his personal funds. F2 · price: The price reported is the weighted average at which the shares were purchased. 10,000 shares were purchased on October 8, 2024, in multiple transactions at prices ranging from $14.29 to 14.64. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| July 05, 2024 Filed Jul 8, 2024 14:48 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 4,438 | $12.52 | $55,563.76 |
DisclosureSEC source: 0001079973-24-001035 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,113 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds. F3 · price: The price reported is the midpoint of the price range at which the shares were purchased. 4,438 shares were purchased on July 5, 2024, in multiple transactions ranging from $12.40 to $12.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 14:48 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 4,562 | $12.29 | $56,066.98 |
DisclosureSEC source: 0001079973-24-001035 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,675 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds. F2 · price: The price reported is the midpoint of the price range at which the shares were purchased. 4,562 shares were purchased on July 3, 2024, in multiple transactions at prices ranging from $11.99 to $12.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 16:01 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 345,086 | $0.80 | $276,068.80 |
DisclosureSEC source: 0001079973-24-000085 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,209,372 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds. F3 · price: 345,086 shares were purchased on January 18, 2024, in multiple transactions at $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:01 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 299,994 | $0.78 | $235,195.30 |
DisclosureSEC source: 0001079973-24-000085 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,864,286 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds. F2 · price: The price reported is the midpoint of the price range at which the shares were purchased. 299,994 shares were purchased on January 17, 2024, in multiple transactions at prices ranging from $0.768 to $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:10 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 100,000 | $0.67 | $66,700.00 |
DisclosureSEC source: 0001079973-23-001645 · ownership.xml · nonDerivative · entry 2 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,564,292 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds. F3 · price: The 100,000 shares purchased on November 21, 2023, were bought in transactions at prices ranging from $0.6666 to $0.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:10 UTC | ASSEMBLY BIOSCIENCES, INC. ASMB · Entity 5216 | PurchaseCommon Stock | 300,000 | $0.72 | $215,400.00 |
DisclosureSEC source: 0001079973-23-001645 · ownership.xml · nonDerivative · entry 1 Schornstein Alexander · CIK 0001999256 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,464,292 F1 · kind: The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds. F2 · price: The price reported is a weighted average price. These shares were purchased on November 20, 2023, in multiple transactions at prices ranging from $0.695 to $0.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.